Saga University
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.saga-u.ac.jp
Clinical Trials
45
Active:2
Completed:18
Trial Phases
5 Phases
Phase 1:1
Phase 2:2
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Not Applicable
38 (84.4%)Phase 4
3 (6.7%)Phase 2
2 (4.4%)Phase 1
1 (2.2%)Phase 3
1 (2.2%)Effect of Dotinurad in Hyperuricemia With Hypertension
Phase 4
Recruiting
- Conditions
- Hyperuricemia or GoutHypertension
- Interventions
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Saga University
- Target Recruit Count
- 360
- Registration Number
- NCT06834230
- Locations
- 🇯🇵
Saga University Hospital, Saga, Japan
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Phase 4
Active, not recruiting
- Conditions
- Chronic Kidney DiseasesType 2 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Saga University
- Target Recruit Count
- 100
- Registration Number
- NCT05887817
- Locations
- 🇯🇵
Saga University Hospital, Saga, Japan
Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)
Phase 4
Active, not recruiting
- Conditions
- Heart Failure
- Interventions
- Drug: Standard treatment
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Saga University
- Target Recruit Count
- 400
- Registration Number
- NCT05164653
- Locations
- 🇯🇵
Saga University Hospital, Saga, Japan
News
No news found